Effectiveness of azacitidine in higher-risk myelodysplastic syndromes
Crossref DOI link: https://doi.org/10.1038/leu.2016.117
Published Online: 2016-05-20
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dinmohamed, A G
van Norden, Y
van de Loosdrecht, A A
Jongen-Lavrencic, M
Text and Data Mining valid from 2016-05-20
Version of Record valid from 2016-05-20
Article History
First Online: 20 May 2016
Competing interests
: The authors declare no conflict of interest.